United States · FDA National Drug Code directory
Naproxen Sodium 220mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69168-395_08dc5597-5820-47c7-aec4-72336b5b7089
- Product NDC
- 69168-395
- Form
- TABLET, COATED
- Composition / generic term
- Naproxen Sodium 220mg
- Labeler
- Allegiant Health
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110504
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, COATED in 1 BOTTLE (69168-395-07) · 69168-395-07
- 300 TABLET, COATED in 1 BOTTLE (69168-395-17) · 69168-395-17
- 50 TABLET, COATED in 1 BOTTLE (69168-395-50) · 69168-395-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →